These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 32017805)

  • 21. Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.
    Verdeguer A; de Heredia CD; González M; Martínez AM; Fernández-Navarro JM; Pérez-Hurtado JM; Badell I; Gómez P; González ME; Muñoz A; Díaz MA;
    Bone Marrow Transplant; 2011 Jan; 46(1):119-24. PubMed ID: 20228849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
    Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
    Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
    Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
    Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor.
    Crocchiolo R; Giordano L; Rimondo A; Bologna M; Sarina B; Morabito L; Bramanti S; Castagna L; Mineri R
    J Clin Virol; 2016 Nov; 84():24-26. PubMed ID: 27669362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
    Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kröger N; Dreger P; Mohty M; Nagler A; Cesaro S
    J Clin Oncol; 2016 Jul; 34(19):2212-20. PubMed ID: 27091716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
    Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
    Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
    Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
    Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].
    Song T; Chen G; Zhang X; Xu Y; Chen J; Wang Y; Ye L; Xu J; Wu D; Miao J
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3135-9. PubMed ID: 25573307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.
    Xuan L; Huang F; Fan Z; Zhou H; Zhang X; Yu G; Zhang Y; Liu C; Sun J; Liu Q
    J Hematol Oncol; 2012 Aug; 5():46. PubMed ID: 22856463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation.
    Huang J; Pan Z; Wang L; Zhang Z; Huang J; Jiang C; Cai G; Yin T
    Clin Exp Med; 2024 Jan; 24(1):22. PubMed ID: 38280072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
    Hill JA; Moon SH; Chandak A; Zhang Z; Boeckh M; Maziarz RT
    Transplant Cell Ther; 2022 Sep; 28(9):619.e1-619.e8. PubMed ID: 35764288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.
    Sahin U; Toprak SK; Atilla PA; Atilla E; Demirer T
    J Infect Chemother; 2016 Aug; 22(8):505-14. PubMed ID: 27344206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation.
    Admiraal R; de Koning CCH; Lindemans CA; Bierings MB; Wensing AMJ; Versluys AB; Wolfs TFW; Nierkens S; Boelens JJ
    J Allergy Clin Immunol; 2017 Dec; 140(6):1643-1650.e9. PubMed ID: 28392330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
    Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
    Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity.
    AlQahtani HY; AlSuhebany N; Alowais SA; AlShehri B; Althemery A; Alghanim A; Alqahtani H; Alkhathran L; Alyaqub M; Alsulimani M; AlHarbi A; Alhatmi H; Almansour S; Almohaya A; Bosaeed M
    Virol J; 2024 Jul; 21(1):149. PubMed ID: 38956615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation].
    Lu Y; Wu T; Cao XY; Wang JB; Sun Y; Zhao YL; DA WM; Ji SQ; Tong CR; Lu DP
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):383-7. PubMed ID: 21624219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.